FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2809743054> ?p ?o ?g. }

• W2809743054 endingPage "2314" @default.
• W2809743054 startingPage "2301" @default.
• W2809743054 abstract "Key points This investigation assessed the influence of group III/IV muscle afferents on small muscle mass exercise performance from a skeletal muscle bioenergetics perspective. Group III/IV muscle afferent feedback was attenuated with lumbar intrathecal fentanyl during intermittent isometric single‐leg knee‐extensor all‐out exercise, while 31 P‐MRS was used to assess skeletal muscle bioenergetics. Attenuation of group III/IV muscle afferent feedback improved exercise performance during the first minute of exercise, due to an increase in total ATP production with no change in the ATP cost of contraction. However, exercise performance was not altered during the remainder of the protocol, despite a sustained increase in total ATP production, due to an exacerbated ATP cost of contraction. These findings reveal that group III/IV muscle afferents directly limit exercise performance during small muscle mass exercise, but, due to their critical role in maintaining skeletal muscle contractile efficiency, with time, the benefit of attenuating the muscle afferents is negated. Abstract The direct influence of group III/IV muscle afferents on exercise performance remains equivocal. Therefore, all‐out intermittent isometric single‐leg knee‐extensor exercise and phosphorous magnetic resonance spectroscopy ( 31 P‐MRS) were utilized to provide a high time resolution assessment of exercise performance and skeletal muscle bioenergetics in control conditions (CTRL) and with the attenuation of group III/IV muscle afferent feedback via lumbar intrathecal fentanyl (FENT). In both conditions, seven recreationally active men performed 60 maximal voluntary quadriceps contractions (MVC; 3 s contraction, 2 s relaxation), while knee‐extensor force and 31 P‐MRS were assessed during each MVC. The cumulative integrated force was significantly greater (8 ± 6%) in FENT than CTRL for the first minute of the all‐out protocol, but was not significantly different for the second to fifth minutes. Total ATP production was significantly greater (16 ± 21%) in FENT than CTRL throughout the all‐out exercise protocol, due to a significantly greater anaerobic ATP production (11 ± 13%) in FENT than CTRL with no significant difference in oxidative ATP production. The ATP cost of contraction was not significantly different between FENT and CTRL for the first minute of the all‐out protocol, but was significantly greater (29 ± 34%) in FENT than in CTRL for the second to fifth minutes. These findings reveal that group III/IV muscle afferents directly limit exercise performance during small muscle mass exercise, but, due to their critical role in maintaining skeletal muscle contractile efficiency, with time, the benefit from muscle afferent attenuation is negated." @default.
• W2809743054 created "2018-07-10" @default.
• W2809743054 creator A5013963285 @default.
• W2809743054 creator A5014184061 @default.
• W2809743054 creator A5016633269 @default.
• W2809743054 creator A5016791114 @default.
• W2809743054 creator A5024186071 @default.
• W2809743054 creator A5043054048 @default.
• W2809743054 creator A5072316562 @default.
• W2809743054 creator A5072763047 @default.
• W2809743054 date "2018-05-08" @default.
• W2809743054 modified "2023-10-17" @default.
• W2809743054 title "Influence of group III/IV muscle afferents on small muscle mass exercise performance: a bioenergetics perspective" @default.
• W2809743054 cites W111397596 @default.
• W2809743054 cites W1497875326 @default.
• W2809743054 cites W1501427097 @default.
• W2809743054 cites W1517094359 @default.
• W2809743054 cites W1522477433 @default.
• W2809743054 cites W1549867379 @default.
• W2809743054 cites W1565099696 @default.
• W2809743054 cites W1571154140 @default.
• W2809743054 cites W1575498217 @default.
• W2809743054 cites W1584612411 @default.
• W2809743054 cites W1595061299 @default.
• W2809743054 cites W1818631042 @default.
• W2809743054 cites W1897241986 @default.
• W2809743054 cites W1968750351 @default.
• W2809743054 cites W1972856038 @default.
• W2809743054 cites W1975255614 @default.
• W2809743054 cites W1975891501 @default.
• W2809743054 cites W1987665794 @default.
• W2809743054 cites W2000296160 @default.
• W2809743054 cites W2005146602 @default.
• W2809743054 cites W2013782500 @default.
• W2809743054 cites W2015054487 @default.
• W2809743054 cites W2016953256 @default.
• W2809743054 cites W2021381433 @default.
• W2809743054 cites W2031657838 @default.
• W2809743054 cites W2037716502 @default.
• W2809743054 cites W2047684905 @default.
• W2809743054 cites W2050008654 @default.
• W2809743054 cites W2050249279 @default.
• W2809743054 cites W2059124201 @default.
• W2809743054 cites W2062229924 @default.
• W2809743054 cites W2063671015 @default.
• W2809743054 cites W2066309233 @default.
• W2809743054 cites W2073168563 @default.
• W2809743054 cites W2073219514 @default.
• W2809743054 cites W2085283271 @default.
• W2809743054 cites W2091850962 @default.
• W2809743054 cites W2094926031 @default.
• W2809743054 cites W2100614612 @default.
• W2809743054 cites W2107387209 @default.
• W2809743054 cites W2110611352 @default.
• W2809743054 cites W2128394280 @default.
• W2809743054 cites W2129261791 @default.
• W2809743054 cites W2130192938 @default.
• W2809743054 cites W2136635431 @default.
• W2809743054 cites W2138094225 @default.
• W2809743054 cites W2141379535 @default.
• W2809743054 cites W2146042119 @default.
• W2809743054 cites W2148350761 @default.
• W2809743054 cites W2150846268 @default.
• W2809743054 cites W2156682186 @default.
• W2809743054 cites W2159009068 @default.
• W2809743054 cites W2162161355 @default.
• W2809743054 cites W2168624904 @default.
• W2809743054 cites W2175276511 @default.
• W2809743054 cites W2195881466 @default.
• W2809743054 cites W2212093853 @default.
• W2809743054 cites W2224460588 @default.
• W2809743054 cites W2268247674 @default.
• W2809743054 cites W2276904486 @default.
• W2809743054 cites W2290457913 @default.
• W2809743054 cites W2318201629 @default.
• W2809743054 cites W2398554671 @default.
• W2809743054 cites W2418253088 @default.
• W2809743054 cites W2536123395 @default.
• W2809743054 cites W2564467607 @default.
• W2809743054 cites W2588431016 @default.
• W2809743054 cites W2740382524 @default.
• W2809743054 cites W4248786683 @default.
• W2809743054 doi "https://doi.org/10.1113/jp275817" @default.
• W2809743054 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6002240" @default.
• W2809743054 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29644702" @default.
• W2809743054 hasPublicationYear "2018" @default.
• W2809743054 type Work @default.
• W2809743054 sameAs 2809743054 @default.
• W2809743054 citedByCount "33" @default.
• W2809743054 countsByYear W28097430542018 @default.
• W2809743054 countsByYear W28097430542019 @default.
• W2809743054 countsByYear W28097430542020 @default.
• W2809743054 countsByYear W28097430542021 @default.
• W2809743054 countsByYear W28097430542022 @default.
• W2809743054 countsByYear W28097430542023 @default.
• W2809743054 crossrefType "journal-article" @default.
• W2809743054 hasAuthorship W2809743054A5013963285 @default.
• W2809743054 hasAuthorship W2809743054A5014184061 @default.

• next